Benzodiazepines and Adequacy of Initial Antidepressant Treatment for Depression
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
In short-term efficacy studies, coprescription of a benzodiazepine improves first-month adherence and response to antidepressant treatment. We used Veterans Health Administration data to examine the impact of coprescribed benzodiazepines on initial antidepressant adherence in routine clinical practice and the risks of long-term benzodiazepine use, abuse, and dependence. Our study population was 43,915 Veterans Health Administration patients diagnosed with depression and started on an antidepressant between October 2006 and September 2007. Using logistic regression, adjusting for demographic and clinical covariates, we predicted the likelihood that patients received antidepressant treatment for an adequate duration (90 days), with our primary independent variable of interest being receipt of a benzodiazepine on the same day as the start of the antidepressant. We also assessed the frequency and characteristics of patients whose benzodiazepine use persisted for 1 year or who were diagnosed with anxiolytic abuse or dependence after receiving combined treatment. The adjusted probability of receiving antidepressant treatment of adequate duration was 42.4% for patients who received a benzodiazepine with their initial antidepressant compared with 39.3% for patients initially treated with an antidepressant alone (P < 0.001). Among patients who received combined treatment, 14.1% subsequently used benzodiazepines for at least 1 year, and 0.7% were diagnosed with anxiolytic abuse or dependence. Anxiolytic abuse or dependence, but not long-term benzodiazepine use, was associated with other substance use disorders. These findings should be considered by clinicians when assessing the individual risks and benefits of combining a benzodiazepine with antidepressant treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Patterns in Antidepressant Medication Treatment
Olfson, M., & Marcus, S. C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.81 · Cited by 730
The diagnosis and management of benzodiazepine dependence
Ashton, H. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165594.60434.84 · Cited by 455 · cited 1×
“Benzodiazepine treatment carries risks of abuse, dependence, and withdrawal symptoms upon discontinuation, particularly with long-term use.(4) Benzodiazepines also increase the risk for cognitive impairment, falls, and hip fractures in the elderly, although the impact of benzodiazepine use on these outcomes may be no…”
BackgroundContinuity of antidepressant treatment for adults with depression in the United States
Olfson, M., Marcus, S. C., Tedeschi, M., & Wan, G. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.101 · Cited by 392
Withdrawal from long-term benzodiazepine treatment
Petursson, H., & Lader, M. H. (1981) · BMJ · doi:10.1136/bmj.283.6292.643 · Cited by 367
Long-term Diazepam Therapy and Clinical Outcome
Rickels, K. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.250.6.767 · Cited by 276
Psychotropic Medications and the Risk of Fracture: A Meta-Analysis
Takkouche, B., Montes-Mart??nez, A., Gill, S. S., & Etminan, M. (2007) · Drug Safety · doi:10.2165/00002018-200730020-00006 · Cited by 204
Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management
Schweizer, E., & Rickels, K. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb05973.x · Cited by 163
Antidepressants plus benzodiazepines for major depression
Furukawa, T. A., Streiner, D., Young, L. T., & Kinoshita, Y. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001026 · Cited by 161 · cited 1×
“Coprescribing a benzodiazepine with an antidepressant reduces the likelihood of treatment dropout because of side effects and results in greater improvement in depression symptoms during the first 4 weeks according to meta-analyses of randomized controlled trials.(3) Whether similar outcomes are obtained in routine cl…”
Background
Research works printed but not linked: 11
- Hanlon, 1998, Benzodiazepine use and cognitive function among community-dwelling elderly., Clin Pharmacol Ther, 64, 684, 10.1016/S0009-9236(98)90059-5 · DOI · Paper page
- Leipzig, 1999, Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs., J Am Geriatr Soc, 47, 30, 10.1111/j.1532-5415.1999.tb01898.x · DOI · Paper page
- Brooks, 2007, Neurocognitive costs and benefits of psychotropic medications in older adults., J Geriatr Psychiatry Neurol, 20, 199, 10.1177/0891988707308803 · DOI · Paper page
- Weilburg, 2003, Evaluation of the adequacy of outpatient antidepressant treatment., Psychiatr Serv, 54, 1233, 10.1176/appi.ps.54.9.1233 · DOI · Paper page
- Charbonneau, 2004, Monitoring depression care-in search of an accurate quality indicator., Med Care, 42, 522, 10.1097/01.mlr.0000127999.89246.a6 · DOI · Paper page
- Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation., J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 · DOI · Paper page
- Akincigil, 2007, Adherence to antidepressant treatment among privately insured patients diagnosed with depression., Med Care, 45, 363, 10.1097/01.mlr.0000254574.23418.f6 · DOI · Paper page
- Smith, 2002, Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?, J Affect Disord, 70, 251, 10.1016/S0165-0327(01)00352-4 · DOI
- Lenze, 2005, Somatic symptoms in late-life anxiety: treatment issues., J Geriatr Psychiatry Neurol, 18, 89, 10.1177/0891988705276251 · DOI · Paper page
- Sheehan, 2008, Differences in medication adherence and healthcare resource utilization patterns older versus newer antidepressant agents in patients with depression and/or anxiety disorders., CNS Drugs, 22, 963, 10.2165/00023210-200822110-00005 · DOI
- Rost, 2005, Clinical improvement associated with conformance to HEDIS-based depression care., Ment Health Serv Res, 7, 103, 10.1007/s11020-005-3781-1 · DOI
Cited by
Benzodiazepines revisited—will we ever learn?
Lader, M. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03563.x · Cited by 573
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Perestelo-Perez, L., Perestelo-Perez, Perez-Ramos, Serrano-Aguilar, & Cuevas, D. L. (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s39382 · Cited by 54
“22,25,35 Comorbid anxiety disorders (except post-traumatic stress disorder, which predicted worse adherence in Pfeiffer et al) 35 was significantly related to better adherence in two studies, 35,42 but another three studies did not show statistically significant results.”
InfluentialUnderstanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology
Lim, B., Sproule, B. A., Zahra, Z., Sunderji, N., Kennedy, S. H., & Rizvi, S. J. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000316 · Cited by 50
Zhang, R., Wiers, C. E., Manza, P., Tomasi, D., Shokri-Kojori, E., Kerich, M., Almira, E., Schwandt, M., Diazgranados, N., Momenan, R., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac127 · Cited by 11
Metadata
- Authors
- Pfeiffer, P. N., Ganoczy, D., Zivin, K., & Valenstein, M.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2011-06
- Volume
- 31
- Issue
- 3
- Pages
- 360-364
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2022826777
- Cited by
- 40
- References
- 8
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Benzodiazepines and Adequacy of Initial Antidepressant Treatment for Depression. https://app.cochat.ai/papers/10.1097/jcp.0b013e318217b4c4
- The paper
- Pfeiffer, P. N., Ganoczy, D., Zivin, K., & Valenstein, M. (2011). Benzodiazepines and Adequacy of Initial Antidepressant Treatment for Depression. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0b013e318217b4c4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.